|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 224.9 USD | +2.21% |
|
+3.16% | -13.07% |
July 28 (Reuters) - Biogen is exploring an acquisition of biotech firm Reata Pharmaceuticals, Bloomberg Law reported on Friday, citing people familiar with the matter.
Shares of Reata surged about 13% in premarket trading. (Reporting by Bhanvi Satija in Bengaluru; Editing by Shinjini Ganguli)
| 1st Jan change | Capi. | |
|---|---|---|
| -13.07% | 32.04B | |
| -2.29% | 89.38B | |
| -3.95% | 37.92B | |
| +63.05% | 26.03B | |
| -22.14% | 14.14B | |
| -7.96% | 12.88B | |
| -9.33% | 11.77B | |
| -46.33% | 10.85B | |
| +5.77% | 8.92B | |
| -17.66% | 7.34B |
BIOGEN INC. 
